Drug
LU Ag06474
LU Ag06474: highest development phase Phase 1, developed by Lundbeck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Lundbeck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lu AG06474 NCT05003687 | Phase 1 | Healthy |
Latest
No recent events.
Follow LU Ag06474 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.